Prognostic role of derived neutrophil to lymphocyte ratio (dNLR) in men with metastatic castration resistant prostate cancer (mCRPC) treated in a phase 3 trial (VENICE).
Arnoud J. Templeton
No relevant relationships to disclose
Francisco Emilio Vera-Badillo
No relevant relationships to disclose
Florence Mercier
Consultant or Advisory Role - Sanofi
Guru Sonpavde
No relevant relationships to disclose
Eitan Amir
No relevant relationships to disclose
Bertrand F. Tombal
No relevant relationships to disclose
Mark Rosenthal
Consultant or Advisory Role - Sanofi
Ian Tannock
Research Funding - Sanofi